Stephen A. Paget, MD, FACP, FACR

Dr. Paget was the Physician-in-Chief and Chairman of the Division of Rheumatology at Hospital For Special Surgery and the Joseph P. Routh Professor of Medicine and Rheumatic Disease at the Weill Medical College of Cornell University and the New York Presbyterian Hospital for fifteen years and is now the Physician-in-Chief Emeritus. As Chair, he developed and ran a world-class rheumatology division of 46 physicians, scientists and clinician-scholar educators who were focused on clinical, perioperative and consultative care throughout HSS and the York Avenue institutions, basic, translational and clinical and drug trials research and musculoskeletal education to medical students, residents and fellows.  

During his time at the NIH and upon arriving at HSS in 1975, his basic immunologic research focused on defining the immunopathogenesis of rheumatoid arthritis. As an Associate Director of an NIH-funded Cornell Multipurpose Arthritis Center, he focused his clinical and translational research on the areas of steroid-induced osteoporosis, systemic vasculitides, rheumatoid arthritis, joint replacements and hip fractures. Most recently, Dr. Paget was a director of the Mary Kirkland Center for Lupus Research at HSS and on the Board of Directors of the Lupus Clinical Trials Consortium and his investigation was directed at attaining a broader understanding of premature atherosclerosis in autoimmune disorders.

He was a Member of the Board of Directors of the American Board of Internal Medicine and the Co-Chair of the rheumatology subspecialty Board and is currently on its rheumatology subspecialty Board. He has been a member of the Board of Directors of the Research and Education Foundation of the American College of Rheumatology and the Chair of its Development Advisory Council. He was recently honored by receiving the American College of Rheumatology’s Master designation and Distinguished Clinical Scholar award. He was a longstanding member of the Board of Trustees of the New York Arthritis Foundation.

Dr. Paget received his MD degree from Downstate Medical Center, did his residency in Internal Medicine at Johns Hopkins and was a Clinical Associate at the National Institute of Arthritis, Musculoskleletal and Skin diseases.

Dr. Paget has both national and international recognition as a Master Clinician in a broad range of inflammatory and autoimmune disorders. As a Clinician-Scholar Educator he has had a significant impact upon rheumatology education and is currently the Director of the HSS Rheumatology Academy of Medical Educators.

Appointments

Physician-in-Chief Emeritus, Hospital for Special Surgery
Stephen A. Paget Rheumatology Leadership Chair

Specialty

Rheumatology

Special Expertise

Autoimmune disorders

Rheumatoid arthritis
Systemic Lupus Erythematosus
Antiphospholipid syndrome
Scleroderma
Sjogren's syndrome
Dermatomyositis/polymyositis
Mixed Connective Tissue disease
Adult-onset Still's disease

Vasculitides

Granulomatosis with polyangiitis (Wegener's Granulomatosis)
Churg Strauss Vasculitis
Giant Cell Arteritis/Polymyalgia Rheumatica
Takayasu's arteritis
Polychondritis

Spondyloarthritis

Psoriatic arthritis
Ankylosing spondylitis
Arthritis associated with Crohn's disease and Ulcerative colitis
Reactive Arthritis/Reiter's syndrome

Osteoathritis, general and spine
Gout
Pseudogout
Sarcoidosis
Tendinitis/Bursitis

Awards

Master of the American College of Rheumatology
Distinguished Clinical Scholar, American College of Rheumatology
HSS Lifetime Achievement Award
Wholeness of Life Award

Affiliations

American College of Rheumatology, Fellow

Education

MD, Downstate Medical Center, Brooklyn, New York
Clinical Associate, National Institutes of Arthritis, Metabolic and Skin Disease

Residency

Johns Hopkins Hospital, Baltimore, Maryland

Fellowship

Hospital for Special Surgery, New York, New York

Certification

Internal Medicine
Rheumatology

State Licensure

New York  

Stephen A. Paget, MD, FACP, FACR has contributed to the following articles on HSS.edu:

Selected Publications

Van Boxel JA, Paget SA. Predominantly T-cell infiltrate in rheumatoid synovial membranes. N Engl J Med 1975;293(11):517-20.

Healey JH, Paget SA, Williams-Russo P, et al. A randomized controlled trial of  salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis  and polymyalgia rheumatica. Calcif Tissue Int 1996;58(2):73-80.

Horton R, Peterson MG, Powell S, Engelhard E, Paget SA. Users evaluate  LupusLine, a telephone peer counseling service. Arthritis Care Res  1997;10(4):257-63.

36. Yee AM, Hotchkiss RN, Paget SA. Adventitial stripping: a digit saving procedure  in refractory Raynaud's phenomenon. J Rheumatol 1998;25(2):269-76.

Spiera RF, Mitnick HJ, Kupersmith M, et al. A prospective, double-blind,  randomized, placebo controlled trial of methotrexate in the treatment of giant cell  arteritis (GCA). Clin Exp Rheumatol 2001;19(5):495-501.

Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated  atherosclerosis in systemic lupus erythematosus. N Engl J Med  2003;349(25):2399-406.

Spiera RF, Kupersmith M, Paget S, Spiera H. Vision loss in giant cell arteritis  patients treated with alternate-day corticosteroids: comment on the article by  Hoffman et al. Arthritis Rheum 2003;48(4):1159-60; author reply 60-1.

Danoff-Burg S, Revenson TA, Trudeau KJ, Paget SA. Unmitigated communion,  social constraints, and psychological distress among women with rheumatoid arthritis. J Pers 2004;72(1):29-46.

Roman MJ, Devereux RB, Schwartz JE, et al. Arterial stiffness in chronic  inflammatory diseases. Hypertension 2005;46(1):194-9.

Mancuso CA, Rincon M, Sayles W, Paget SA. Longitudinal study of negative  workplace events among employed rheumatoid arthritis patients and healthy controls. Arthritis Rheum 2005;53(6):958-64

Roman MJ, Moeller E, Davis A, Paget SA, et al. Preclinical carotid  atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006;144(4):249-56.

Mancuso CA, Rincon M, Sayles W, Paget SA. Psychosocial variables and  fatigue: a longitudinal study comparing individuals with rheumatoid arthritis and healthy controls. J Rheumatol 2006;33(8):1496-502.

Farzaneh-Far A, Roman MJ, Lockshin MD, et al. Relationship of  antiphospholipid antibodies to cardiovascular manifestations of systemic lupus  erythematosus. Arthritis Rheum 2006;54(12):3918-25.

McIlvane JM, Schiaffino KM, Paget SA. Age differences in the pain-depression link for women with osteoarthritis Functional Impairment and Personal Control as Mediators. Womens Health Issues 2007;17(1):44-51

Allegrante JP, Peterson MG, Cornell CN, MacKenzie RC, Robbins L, Horton R, Ganz SB, Ruchlin HS, Russo PW, Paget SA, et al. Methodological Challenges of Multiple-Component Intervention : Lessons Learned from a Randomized Controlled Trial of Functional Recovery After Hip Fracture. HSS J. 2007. 3 63-70

Klareskog L, Catrina AI, Paget S. Seminar: Rheumatoid Arthritis. Lancet. 2009;373 (9664) 659-72

Berman JR, Lazaro D, Fields T, Paget SA et al The New York City Rheumatology Objective Structure Clinical Examination: Five-year data demonstrates its validity, usefulness as a unique rating tool, objectivity and sensitivity to change. Arthritis Rheumatism 2009; 61: 1686-93.
 
Charavarty SD, Yee AF, Paget SA. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. J Allergy Clin Immunol. 2011 Dec;128(6):1354-5.

Peterson JC, Paget SA, Lachs MS, Reid MC, Charlson ME. The risk of comorbidity. Ann Rheum Dis. 2012 Feb 2.

For more publications, please see the PubMed listing.  

Research Description

Clinical investigation into the pathogenesis and optimal treatment of rheumatoid arthritis, systemic lupus erythematosus, the systemic vasculitides, premature atherosclerosis associated with autoimmune disorders and steroid-induced osteoporosis.

Clinical Trials

• Autoimmune Disease Registry and Repository
• A Study of Hyaluronan (Synvisc) for the Treatment of Osteoarthritis in the Thumb: Randomized Control Trial
• Database of the Gosden Robinson Early Arthritis Center (EAC): Analysis of Types of Patients Recruited to an Urban EAC
• CORRONA Data Collection Program

 

Mission Statement:

Welcome to our practice. My staff and I are committed to providing you with the best possible rheumatology care anywhere in the setting of a warm, caring, supportive office environment that is aimed at improving the quality of your life. I will share my over 35 years of medical and rheumatology expertise with you, and we will both work toward developing a close partnership that will keep you as healthy as possible, no matter what your current state of health is.

My main aim is to be available for you for any problems that may arise. To this end, I will give you my email address at the end of your first visit because I believe that it is a superb way to communicate. However, for those of you who do not use email, you can contact me via telephone, facsimile, mail or in person.